Product Information
ME-NAPHOS-MB-HYO 1 TABLET is a generic product labeled by Method Pharmaceuticals LLC, priced at $3.9761 per EA under NDC 58657045401. Its NADAC has been published 317 times since Sep 9, 2020.
Strength
.12; 81.6; 10.8; 40.8 mg/1; mg/1; mg/1; mg/1
Manufacturer
Method Pharmaceuticals LLCNDC
58657045401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYOSCYAMINE SULFATE ANHYDROUS; METHENAMINE; METHYLENE BLUE ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEApproval Type
Unapproved
On Market Since
12/1/2015
Pharmacological Classes
Price Statistics
The NADAC for ME-NAPHOS-MB-HYO 1 TABLET has been published 317 times since Sep 9, 2020, and over the history we have for it it has risen 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.9761 per EA |
|---|---|
| All-time high | $4.4378 (Oct 11, 2023) |
| All-time low | $2.5690 (May 18, 2022) |
| 52-week high | $4.3013 |
| 52-week low | $3.8467 |
| Median price | $3.7158 |
| Average price | $3.6803 |
| Largest weekly change | -36.6% (May 18, 2022) |
| Weeks tracked | 317 |
| Tracking since | Sep 9, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Urinary Antiseptic Antispasmodic market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Method Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Urinary Antiseptic Antispasmodic market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Oxidation-Reduction Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ME-NAPHOS-MB-HYO 1 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ME-NAPHOS-MB-HYO 1 TABLET, manufactured by Method Pharmaceuticals LLC, is $3.9761 per EA (NDC 58657045401), effective Sep 30, 2026.
How has the price of ME-NAPHOS-MB-HYO 1 TABLET changed over time?
Over the history we have for it, the NADAC for ME-NAPHOS-MB-HYO 1 TABLET has risen 6.1%. It has been tracked across 317 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for ME-NAPHOS-MB-HYO 1 TABLET?
Since Sep 9, 2020, the NADAC for ME-NAPHOS-MB-HYO 1 TABLET has ranged from a low of $2.5690 (May 18, 2022) to a high of $4.4378 (Oct 11, 2023), with a median of $3.7158 per EA.
Are there cheaper alternatives to ME-NAPHOS-MB-HYO 1 TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ME-NAPHOS-MB-HYO 1 TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ME-NAPHOS-MB-HYO 1 TABLET?
ME-NAPHOS-MB-HYO 1 TABLET (NDC 58657045401) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.